Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 27 clinical trials
None
Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma

This is a randomized, placebo-controlled and double-blind study to evaluate the efficacy and safety of FB825 in adult patients with moderate-to-severe allergic asthma.

  • 0 views
  • 22 Aug, 2021
  • 4 locations
None
A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)

responsive HILD (Histamine Lontophoresis with Laser Doppler monitoring) phenotypes with uncontrolled persistent allergic asthma using Levocetirizine (LTZ) vs placebo.

  • 0 views
  • 13 Jun, 2021
  • 1 location
None
Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma

respiratory disease and allergic asthma and rhinitis. They must also have completed aspirin desensitization and be taking aspirin on a daily basis for the treatment of AERD.

allergic asthma
rhinitis
aspirin
asthma
respiratory disorder
  • 41 views
  • 07 Nov, 2020
  • 1 location
None
Safety Study of Anti-Asthma Agent BMEC-1217B

asthma and can also improve lung function in a mouse model of allergic asthma. The purpose of this study is to evaluate the safety and tolerability of increasing dose of BMEC-1217B when

allergic asthma
pulmonary function test
  • 21 views
  • 07 Nov, 2020
  • 1 location
None
Diagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy Explorer Version 2 (ALEX ) - IgE Multiplex Test for the Diagnosis of Pre-defined Groups of Specific High-priority Allergens

complications, like allergic asthma, later in their life. The sooner the allergen source is identified, the sooner the therapeutic intervention (e.g. dietary recommendations, allergen avoidance, anti

  • 11 views
  • 09 Sep, 2021
  • 2 locations
None
Lung-Resident Memory Th2 Cells in Asthma

Determining how memory T helper type 2 (Th2) initiate recall responses to aeroallergens has the potential to change the therapeutic approach to allergic asthma, the most common asthma subtype

  • 17 views
  • 26 Jan, 2021
  • 1 location
None
To Identify Persons Who Are Susceptible to WSP-induced Inflammation and Examine the Role of GSTM1 and Other Factors in This Susceptibility

Purpose: This screening protocol is designed to assess PMN (neutrophil) responsiveness to wood smoke particles (WSP) and the effect of the GSTM1 null genotype on this response. The researches will identify persons responsive and resistant to the inflammatory effect of WSP. It is anticipated that the GSTM1 genotype will be …

  • 4 views
  • 12 May, 2021
  • 1 location
None
A Double Masked Placebo Controlled Single Center Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC)

A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of ADX-629 in Subjects with Mild Asthma Induced by the Bronchial Allergen Challenge (BAC)

  • 0 views
  • 02 Feb, 2021
  • 1 location
None
Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease

The purpose of this study is to evaluate a previously FDA-approved medication that is known to help with allergy symptoms to see if it can decrease symptoms in patients with Meniere's Disease.

  • 0 views
  • 09 Apr, 2021
  • 3 locations
None
Non-coding RNAs Analysis of Eosinophil Subtypes in Asthma

predominant eosinophils subtype in allergic asthma are iEOS, while rEOS are basic subtype in severe eosinophilic asthma patients, moreover, they are different in adhesive properties and survivability as well

  • 0 views
  • 26 Jan, 2021
  • 1 location